Results 61 to 70 of about 25,229,305 (191)

Heel Pain in Behcet`s Disease

, 1995
Objectives: To evaluate the clinical significance of heel pain, a frequently associated enthesopathy in Behcet`s disease and to evaluate the association with seronegative spondyloarthropathy.
이수곤
core  

Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma Complicating Long‐Standing Immunosuppressed Dermatomyositis

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma (PCGD‐TCL) is a rare cytotoxic lymphoma with key oncogenic drivers in the JAK/STAT pathway. Also primarily involving the subcutaneous adipose tissue, subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is more frequently encountered in scenarios of autoimmune disorders.
Bennett Christie‐Nguyen, Youn H. Kim, David F. Fiorentino, Danielle Tartar, Ryanne Brown, Robert A. Novoa, Kerri E. Rieger   +6 more
wiley   +1 more source

Behcet’s Disease Presenting With Bilateral Hypopyon Masquerading Post Cataract Surgery Endophthalmitis

International Medical Case Reports Journal, 2019
Mehrdad Mohammadpour, Meysam Kosari, Masoud Khorrami-Nejad Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranCorrespondence: Mehrdad MohammadpourEye Research Center, Farabi Eye Hospital, Tehran University of ...
Mohammadpour M, Kosari M, Khorrami-Nejad M   +2 more
doaj  

Pulmonary manifestations in a group of patients with Behçet′s disease

The Egyptian Journal of Internal Medicine, 2015
Background and aim Behçet′s disease (BD) is a multisystem vasculitis and pulmonary involvement in BD is reported to indicate a poor prognosis and high mortality.
Sherif M Naguib, Manal M El Menyawi, Mona I Nabih, Ihab Ismail   +3 more
doaj   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, Matthias Augustin, Falk G. Bechara, Pierre‐André Becherel, Farida Benhadou, Vincenzo Bettoli, Joana Cabete, Raffaele Dante Caposiena Caro, Antonella Di Cesare, Giovanni Damiani, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Krisztián Gáspár, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Barbara Horvath, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Alexander Katoulis, Natalia Kirsten, Georgios Kokolakis, Piotr K. Krajewski, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Andreas Pinter, Anna Pirogova, Maurizio Podda, Francesca Prignano, Jorge Romani, Marco Romanelli, Elia Rosi, Samed Sahin, Ditte M. L. Saunte, Sylke Schneider‐Burrus, Mariano Suppa, Jacek Szepietowski, Andrea Szegedi, Simon Francis Thomsen, Thrasyvoulos Tzellos, Anastasia Trigoni, Hessel H. Van Der Zee, Kelsey Van Straalen, Skaidra Valiukevičiene, Eva Vilarrasa, Esther von Stebut, Christos C. Zouboulis   +54 more
wiley   +1 more source

A strong association between HLA-B(*)5101 and Behcet's disease in Greek patients

, 1997
Behcet's disease is known to be associated with HLA-B51, one of the split antigens of HLA-B5, among many different ethnic groups. In a Greek population, an increased incidence of HLA-B5 in the patient group has also been reported.
Isobe, K., Ohno, S., Stavropoulos-Ghiokas, E., Palimeris, G.D., Mizuki, N., Ito, N., Goto, K., Shindo, Y., Chen, L., Inoko, H., Nakamura, S., Ando, H., Ishihara, M.   +12 more
core   +1 more source

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos, Evangelos J. Giamarellos‐Bourboulis, Kelsey R. van Straalen, Antonio Martorell, Brian Kirby, Afsaneh Alavi, Koremasa Hayama, Saakshi Khattri, Wayne Gulliver, Christopher J. Sayed, Leah Davis, Robert L. Rolleri, Christina Crater, Ingrid Pansar, Jérémy Lambert, Christos C. Zouboulis   +15 more
wiley   +1 more source

Renal involvement in behcet′s disease

Saudi Journal of Kidney Diseases and Transplantation, 2009
There are conflicting reports about the renal involvement in Behcet′s disease (BD). In this study we aimed to study the frequency and type of renal involvement in a group of patients with BD in Azerbaijan province that is one of the prevalent ...
Ardalan Mohammad, Sadreddini Shahram, Noshad Hamid, Ebrahimi Aliasghar, Molaeefard Mahsheed, Somi Mohammad, Shoja Mohammadali   +6 more
doaj  

Young Children With Behcet Disease Have More Intestinal Involvement

, 2014
Objective:Gastrointestinal (GI) involvement in childhood Behcet disease (BD) is not well understood. We aimed to clarify the intestinal presentation in children with BD.Methods:Medical records of 85 children with recurrent oral ulcers between 1990 and ...
王麗潔 ;林于粲 ;李志鴻 ;俞欣慧 ;陳思達 ;江伯倫 ;楊曜旭, Hung, Chien-Hui;Lee, Jyh-Hong;Chen, Szu-Ta;Yang, Yao-Hsu;Lin, Yu-Tsan;Wang, Li-Chieh;Yu, Hsin-Hui;Chiang, Bor-Luen   +1 more
core  

Acute optic neuropathy in patients with Behcet\u27s disease - Report of two cases

, 2006
Although acute optic neuropathy has been rarely reported in patients with Behcet\u27s disease, a detailed description of its clinical course is lacking.
Pandit R, Voros GM, Sandhu SS
core   +5 more sources